Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TOUR: Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study

NCT03772145 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT03772145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03772145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TOUR: Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Observational
Overall status
Terminated
Start date
November 27, 2018
Completion date
January 29, 2024
Enrollment
103 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis